GABAA Receptor-Modulating Steroids in Relation to Women’s Behavioral Health

In certain women, increased negative mood relates to the progesterone metabolite, allopregnanolone (allo), during the luteal phase of ovulatory menstrual cycles, the premenstrual dysphoric disorder (PMDD). In anovulatory cycles, no symptom or sex steroid increase occurs but symptoms return during pr...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Current psychiatry reports Ročník 17; číslo 11; s. 92
Hlavní autori:	Bäckström, Torbjörn, Bixo, Marie, Strömberg, Jessica
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	New York Springer US 01.11.2015 Springer Nature B.V
Predmet:	Affect - drug effects Affect - physiology Female GABA Modulators - metabolism GABA Modulators - pharmacology Humans Medicine Medicine & Public Health Menstrual Cycle - drug effects Menstrual Cycle - metabolism Neurotransmitters Pregnanolone - metabolism Premenstrual Dysphoric Disorder - metabolism Premenstrual Dysphoric Disorder - psychology Premenstrual Dysphoric Disorder - therapy Psychiatry Receptors, GABA-A - metabolism Section Editor Steroids Topical Collection on Women's Mental Health Women's Mental Health (CN Epperson GABA Mood symptoms receptor-modulating steroids Premenstrual dysphoric disorder GABAA receptor-modulating steroids
ISSN:	1523-3812, 1535-1645, 1535-1645
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	In certain women, increased negative mood relates to the progesterone metabolite, allopregnanolone (allo), during the luteal phase of ovulatory menstrual cycles, the premenstrual dysphoric disorder (PMDD). In anovulatory cycles, no symptom or sex steroid increase occurs but symptoms return during progesterone/allo treatment. Allo is a potent GABA A receptor-modulating steroid and as such is expected to be calming and anxiolytic. A relation to negative mood is unexpected. However, this paradoxical effect can be induced by all GABA A receptor modulators in low concentrations whereas higher concentrations are calming. The severity of the mood symptoms relate to allo in an inverted U-shaped curve at endogenous luteal-phase serum concentrations. Allo’s effects on the GABA A receptor can be antagonized by isoallopregnanolone (ISO), an antagonist to allo. ISO has also been used in a preliminary clinical trial on PMDD ameliorating symptoms with good effect in PMDD patients.
AbstractList	In certain women, increased negative mood relates to the progesterone metabolite, allopregnanolone (allo), during the luteal phase of ovulatory menstrual cycles, the premenstrual dysphoric disorder (PMDD). In anovulatory cycles, no symptom or sex steroid increase occurs but symptoms return during progesterone/allo treatment. Allo is a potent GABAA receptor-modulating steroid and as such is expected to be calming and anxiolytic. A relation to negative mood is unexpected. However, this paradoxical effect can be induced by all GABAA receptor modulators in low concentrations whereas higher concentrations are calming. The severity of the mood symptoms relate to allo in an inverted U-shaped curve at endogenous luteal-phase serum concentrations. Allo's effects on the GABAA receptor can be antagonized by isoallopregnanolone (ISO), an antagonist to allo. ISO has also been used in a preliminary clinical trial on PMDD ameliorating symptoms with good effect in PMDD patients.In certain women, increased negative mood relates to the progesterone metabolite, allopregnanolone (allo), during the luteal phase of ovulatory menstrual cycles, the premenstrual dysphoric disorder (PMDD). In anovulatory cycles, no symptom or sex steroid increase occurs but symptoms return during progesterone/allo treatment. Allo is a potent GABAA receptor-modulating steroid and as such is expected to be calming and anxiolytic. A relation to negative mood is unexpected. However, this paradoxical effect can be induced by all GABAA receptor modulators in low concentrations whereas higher concentrations are calming. The severity of the mood symptoms relate to allo in an inverted U-shaped curve at endogenous luteal-phase serum concentrations. Allo's effects on the GABAA receptor can be antagonized by isoallopregnanolone (ISO), an antagonist to allo. ISO has also been used in a preliminary clinical trial on PMDD ameliorating symptoms with good effect in PMDD patients. In certain women, increased negative mood relates to the progesterone metabolite, allopregnanolone (allo), during the luteal phase of ovulatory menstrual cycles, the premenstrual dysphoric disorder (PMDD). In anovulatory cycles, no symptom or sex steroid increase occurs but symptoms return during progesterone/allo treatment. Allo is a potent GABAA receptor-modulating steroid and as such is expected to be calming and anxiolytic. A relation to negative mood is unexpected. However, this paradoxical effect can be induced by all GABAA receptor modulators in low concentrations whereas higher concentrations are calming. The severity of the mood symptoms relate to allo in an inverted U-shaped curve at endogenous luteal-phase serum concentrations. Allo’s effects on the GABAA receptor can be antagonized by isoallopregnanolone (ISO), an antagonist to allo. ISO has also been used in a preliminary clinical trial on PMDD ameliorating symptoms with good effect in PMDD patients. In certain women, increased negative mood relates to the progesterone metabolite, allopregnanolone (allo), during the luteal phase of ovulatory menstrual cycles, the premenstrual dysphoric disorder (PMDD). In anovulatory cycles, no symptom or sex steroid increase occurs but symptoms return during progesterone/allo treatment. Allo is a potent GABA A receptor-modulating steroid and as such is expected to be calming and anxiolytic. A relation to negative mood is unexpected. However, this paradoxical effect can be induced by all GABA A receptor modulators in low concentrations whereas higher concentrations are calming. The severity of the mood symptoms relate to allo in an inverted U-shaped curve at endogenous luteal-phase serum concentrations. Allo’s effects on the GABA A receptor can be antagonized by isoallopregnanolone (ISO), an antagonist to allo. ISO has also been used in a preliminary clinical trial on PMDD ameliorating symptoms with good effect in PMDD patients.
ArticleNumber	92
Author	Bixo, Marie Strömberg, Jessica Bäckström, Torbjörn
Author_xml	– sequence: 1 givenname: Torbjörn surname: Bäckström fullname: Bäckström, Torbjörn email: torbjorn.c.backstrom@umu.se organization: Department of Clinical sciences, Obstetrics and Gynecology, Umeå neurosteroid research center, Umeå University – sequence: 2 givenname: Marie surname: Bixo fullname: Bixo, Marie organization: Department of Clinical sciences, Obstetrics and Gynecology, Umeå neurosteroid research center, Umeå University – sequence: 3 givenname: Jessica surname: Strömberg fullname: Strömberg, Jessica organization: Department of Clinical sciences, Obstetrics and Gynecology, Umeå neurosteroid research center, Umeå University
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/26396092$$D View this record in MEDLINE/PubMed
BookMark	eNp9kctKXTEUhkNR6qV9gE7KBiedRHPZO5fhUeoFFEGFDkNOsrZu2Sc5JtlCZ30NX69P0hyPtiDUURbJ92Ut1r-DNkIMgNAXSvYpIfIgU6oZwYR2mAgmcfsBbdOOd5iKtttY1YxjrijbQjs53xPCCFHsI9pigmtBNNtGFyezw9msuQIHyxITvoh-Gm0Zwm1zXSDFwedmCPV9dRlDU2LzIy4g_P71lJtDuLOPQ0x2bE7BjuXuE9rs7Zjh88u5i26Ov98cneLzy5Ozo9k5dlyygntQTkrmrG872VOqFHA7F71wTvMWVFcL2gIhFDwTtPdeMaG9FkB6Ofd8F31bf7tM8WGCXMxiyA7G0QaIUzZUUtlK3mld0b036H2cUqjDGdYSoYnqlKrU1xdqmi_Am2UaFjb9NK97qgBdAy7FnBP0fxFKzCoLs87C1CzMKgvTVke-cdxQnrdYkh3Gd022NnPtEm4h_Rv6_9IfmzOcTg
CitedBy_id	crossref_primary_10_1007_s43032_023_01375_w crossref_primary_10_1016_j_jsbmb_2015_12_011 crossref_primary_10_1016_j_neubiorev_2024_105842 crossref_primary_10_1038_s41380_024_02566_w crossref_primary_10_1155_2022_3618090 crossref_primary_10_1176_appi_focus_23021035 crossref_primary_10_1016_j_bpobgyn_2020_06_001 crossref_primary_10_1038_s41467_023_40800_1 crossref_primary_10_1586_17512433_2016_1142371 crossref_primary_10_1007_s13300_024_01585_8 crossref_primary_10_1016_j_lfs_2023_121606 crossref_primary_10_1080_09540261_2018_1553775 crossref_primary_10_3389_fnins_2022_885321 crossref_primary_10_1016_j_jep_2025_120242 crossref_primary_10_1016_j_yfrne_2020_100856 crossref_primary_10_1176_appi_ajp_2020_19080848 crossref_primary_10_2147_IJWH_S297062 crossref_primary_10_3390_ijms23147989 crossref_primary_10_1002_jdn_10347 crossref_primary_10_1016_j_pharmthera_2022_108299 crossref_primary_10_1016_j_yfrne_2024_101160 crossref_primary_10_1016_j_yfrne_2024_101171 crossref_primary_10_1097_YCO_0000000000000786 crossref_primary_10_1007_s11062_020_09841_w
Cites_doi	10.1016/S0006-8993(03)02939-1 10.1080/09513590701253511 10.1210/jcem-72-2-252 10.3109/00016348809004191 10.1016/S0016-5107(94)70020-6 10.1016/S0306-4603(00)00175-1 10.1007/BF02244652 10.1016/S0010-9452(13)80139-6 10.1046/j.1365-201x.2000.00744.x 10.1016/j.yhbeh.2003.04.002 10.1016/S0893-133X(97)00086-9 10.1901/jeab.1992.58-577 10.1016/S0306-4530(96)00035-2 10.1016/S0006-8993(97)00455-1 10.1056/NEJM199801223380401 10.1080/j.1600-0412.2000.079005405.x 10.15288/jsa.1996.57.178 10.1016/j.maturitas.2005.11.005 10.1016/0306-4530(90)90072-H 10.1176/ajp.156.6.902 10.1001/archpsyc.62.3.282 10.1176/ajp.155.7.910 10.1016/j.neuroscience.2006.07.031 10.1016/j.psyneuen.2004.07.003 10.1186/2045-5380-4-3 10.1212/WNL.54.8.1691 10.1196/annals.1286.005 10.1111/apha.12100 10.1089/jwh.2013.4674 10.1007/s00213-006-0417-0 10.1016/S0306-4530(03)00121-5 10.1097/00006842-198312000-00004 10.1016/S0306-4530(03)00026-X 10.1016/j.pneurobio.2013.07.005 10.1111/j.1600-0412.2012.01536.x 10.1016/j.ajog.2009.03.016 10.1016/j.psyneuen.2014.10.025 10.1016/S0028-3908(02)00341-6 10.1016/j.jad.2007.09.015 10.1212/WNL.38.8.1233 10.1210/jc.2005-2785 10.1210/jc.2004-0444 10.1007/s00213-014-3776-y 10.1210/jc.2002-020755 10.1159/000054307 10.1016/j.mce.2005.04.007 10.1111/j.1365-2125.1981.tb01844.x 10.1016/j.psyneuen.2014.07.025 10.1523/JNEUROSCI.1715-07.2007 10.1523/JNEUROSCI.15-06-04641.1995 10.1176/appi.books.9780890425596 10.1080/gye.16.1.1.8 10.1097/00003643-200112000-00002 10.1530/acta.0.1250132 10.1038/sj.mp.4002030 10.1007/s00737-013-0346-y 10.1007/s00213-004-1987-3 10.1001/archpsyc.1990.01810180034006 10.1016/j.ejphar.2005.01.049
ContentType	Journal Article
Copyright	Springer Science+Business Media New York 2015 Springer Science+Business Media New York 2015.
Copyright_xml	– notice: Springer Science+Business Media New York 2015 – notice: Springer Science+Business Media New York 2015.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7XB 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ M2M PHGZM PHGZT PKEHL PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8
DOI	10.1007/s11920-015-0627-4
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) Psychology Database (Alumni) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Psychology Database ProQuest Central Premium ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest Central Basic ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central Health Research Premium Collection ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest Central Korea ProQuest One Academic ProQuest Central (New) ProQuest Central (Alumni) ProQuest One Academic (New) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic ProQuest One Psychology MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1535-1645
ExternalDocumentID	26396092 10_1007_s11920_015_0627_4
Genre	Research Support, Non-U.S. Gov't Journal Article Review
GroupedDBID	--- -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29F 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5VS 6NX 6PF 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHQT ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACREN ACSNA ACZOJ ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGAL AEGNC AEGXH AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFKRA AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ AXYYD AZQEC B-. BA0 BDATZ BENPR BGNMA BSONS C1A CAG CCPQU COF CS3 CSCUP CUW DDRTE DNIVK DPUIP DWQXO EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 H13 HF~ HG6 HMJXF HRMNR HZ~ IJ- IKXTQ IMOTQ ITM IWAJR IXC I~Z J-C JBSCW JZLTJ KOV LLZTM M2M M4Y MA- NPVJJ NQJWS NU0 O9- O9J OVD P9S PF0 PQQKQ PSYQQ PT4 PT5 QOR QOS R89 R9I RNI ROL RPX RSV RZK S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TEORI TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR Z7U Z81 Z82 Z83 Z87 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFFHD AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK PKEHL PQEST PQUKI PRINS Q9U 7X8
ID	FETCH-LOGICAL-c372t-fe8c772cad457f1188e3ab6f6cc934e856cc14e001ed261fdd8269d96e0f7bd3
IEDL.DBID	BENPR
ISICitedReferencesCount	25
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000361741100007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1523-3812 1535-1645
IngestDate	Sun Nov 09 13:56:00 EST 2025 Wed Nov 26 14:52:25 EST 2025 Thu Apr 03 07:06:02 EDT 2025 Sat Nov 29 03:10:23 EST 2025 Tue Nov 18 20:45:59 EST 2025 Fri Feb 21 02:41:11 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	11
Keywords	GABA Mood symptoms receptor-modulating steroids Premenstrual dysphoric disorder GABAA receptor-modulating steroids
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c372t-fe8c772cad457f1188e3ab6f6cc934e856cc14e001ed261fdd8269d96e0f7bd3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
PMID	26396092
PQID	2406908588
PQPubID	4402920
ParticipantIDs	proquest_miscellaneous_1717473599 proquest_journals_2406908588 pubmed_primary_26396092 crossref_primary_10_1007_s11920_015_0627_4 crossref_citationtrail_10_1007_s11920_015_0627_4 springer_journals_10_1007_s11920_015_0627_4
PublicationCentury	2000
PublicationDate	2015-11-01
PublicationDateYYYYMMDD	2015-11-01
PublicationDate_xml	– month: 11 year: 2015 text: 2015-11-01 day: 01
PublicationDecade	2010
PublicationPlace	New York
PublicationPlace_xml	– name: New York – name: United States
PublicationTitle	Current psychiatry reports
PublicationTitleAbbrev	Curr Psychiatry Rep
PublicationTitleAlternate	Curr Psychiatry Rep
PublicationYear	2015
Publisher	Springer US Springer Nature B.V
Publisher_xml	– name: Springer US – name: Springer Nature B.V
References	Schmidt, Nieman, Danaceau, Adams, Rubinow (CR14) 1998; 338 Wang, Backstrom, Landgren (CR49) 2000; 169 CR39 Dougherty, Cherek, Bennett (CR30) 1996; 57 CR38 Mortola, Girton, Fischer (CR12) 1991; 72 CR37 CR36 Lundgren, Stromberg, Backstrom, Wang (CR48) 2003; 982 Hall, Zisook (CR21) 1981; 11 Hammarback, Backstrom (CR10) 1988; 67 CR33 CR31 Weerts, Tornatzky, Miczek (CR34) 1993; 110 CR2 CR4 CR3 CR6 CR8 CR9 CR47 CR46 Cherek, Spiga, Egli (CR29) 1992; 58 CR43 Bixo, Andersson, Winblad, Purdy, Backstrom (CR13) 1997; 764 Andreen, Spigset, Andersson, Nyberg, Backstrom (CR35) 2006; 54 CR42 CR41 CR40 Cheney, Uzunov, Costa, Guidotti (CR57) 1995; 15 Sveindottir, Backstrom (CR26) 2000; 79 Sundstrom, Nyberg, Backstrom (CR44) 1997; 17 CR19 CR18 CR17 CR16 CR15 CR59 CR58 CR56 CR11 CR55 CR54 CR53 Sundstrom, Ashbrook, Backstrom (CR45) 1997; 22 CR52 CR51 CR50 Honan (CR22) 1994; 40 Nyberg, Backstrom, Zingmark, Purdy, Poromaa (CR1) 2007; 23 Kurthen, Linke, Reuter, Hufnagel, Elger (CR27) 1991; 27 (CR5) 2001; 73 CR28 Miczek, Fish, De Bold (CR32) 2003; 44 CR25 CR24 CR20 CR63 CR62 CR61 CR60 Sundstrom Poromaa, Gingnell (CR7) 2014; 8 Ben-Porath, Taylor (CR23) 2002; 27 627_CR62 627_CR61 627_CR60 EM Weerts (627_CR34) 1993; 110 I Sundstrom Poromaa (627_CR7) 2014; 8 627_CR28 JF Mortola (627_CR12) 1991; 72 DR Cherek (627_CR29) 1992; 58 627_CR20 627_CR63 MD Wang (627_CR49) 2000; 169 627_CR25 ACOG American College of Obstetricians and Gynecologists, ACOG practice bulletin (627_CR5) 2001; 73 627_CR24 627_CR51 627_CR50 L Andreen (627_CR35) 2006; 54 I Sundstrom (627_CR44) 1997; 17 627_CR19 P Lundgren (627_CR48) 2003; 982 627_CR18 627_CR17 627_CR16 627_CR11 627_CR55 627_CR54 627_CR53 627_CR52 627_CR15 627_CR59 S Hammarback (627_CR10) 1988; 67 627_CR58 627_CR56 DL Cheney (627_CR57) 1995; 15 627_CR40 PJ Schmidt (627_CR14) 1998; 338 H Sveindottir (627_CR26) 2000; 79 627_CR2 I Sundstrom (627_CR45) 1997; 22 M Bixo (627_CR13) 1997; 764 DM Dougherty (627_CR30) 1996; 57 RC Hall (627_CR21) 1981; 11 DD Ben-Porath (627_CR23) 2002; 27 627_CR43 VJ Honan (627_CR22) 1994; 40 627_CR42 627_CR41 S Nyberg (627_CR1) 2007; 23 627_CR47 627_CR46 M Kurthen (627_CR27) 1991; 27 627_CR9 627_CR39 627_CR8 627_CR38 627_CR6 627_CR3 627_CR4 627_CR33 627_CR31 627_CR37 627_CR36 KA Miczek (627_CR32) 2003; 44 23510409 - Acta Physiol (Oxf). 2013 Aug;208(4):400-9 9435325 - N Engl J Med. 1998 Jan 22;338(4):209-16 10830769 - Acta Obstet Gynecol Scand. 2000 May;79(5):405-13 14609546 - Horm Behav. 2003 Sep;44(3):242-57 15316711 - Psychopharmacology (Berl). 2005 Mar;178(2-3):232-40 10951125 - Acta Physiol Scand. 2000 Aug;169(4):333-41 15471618 - Psychoneuroendocrinology. 2005 Feb;30(2):212-24 14993039 - Ann N Y Acad Sci. 2003 Dec;1007:42-53 25222701 - Psychoneuroendocrinology. 2014 Dec;50:28-52 14604604 - Psychoneuroendocrinology. 2004 Feb;29(2):245-68 15814085 - Eur J Pharmacol. 2005 Apr 4;512(1):15-21 17942736 - J Neurosci. 2007 Oct 17;27(42):11416-23 3399074 - Neurology. 1988 Aug;38(8):1233-6 11737177 - Eur J Anaesthesiol. 2001 Dec;18(12):789-97 25345735 - Psychopharmacology (Berl). 2016 Jun;233(11):2025-33 10360130 - Am J Psychiatry. 1999 Jun;156(6):902-7 12727949 - J Clin Endocrinol Metab. 2003 May;88(5):2026-30 9295207 - Brain Res. 1997 Aug 1;764(1-2):173-8 3140572 - Acta Obstet Gynecol Scand. 1988;67(2):159-66 6686333 - Psychosom Med. 1983 Dec;45(6):503-7 12915239 - Brain Res. 2003 Aug 22;982(1):45-53 16406399 - Maturitas. 2006 Jun 20;54(3):238-44 15486056 - J Clin Endocrinol Metab. 2005 Jan;90(1):395-403 22924787 - Acta Obstet Gynecol Scand. 2012 Dec;91(12):1445-52 6133541 - Br J Clin Pharmacol. 1981;11 Suppl 1:99S-104S 17579609 - Mol Psychiatry. 2008 Mar;13(3):325-33 8683967 - J Stud Alcohol. 1996 Mar;57(2):178-86 2161643 - Arch Gen Psychiatry. 1990 Jun;47(6):534-8 23978486 - Prog Neurobiol. 2014 Feb;113:88-94 17558683 - Gynecol Endocrinol. 2007 May;23(5):257-66 9141149 - Psychoneuroendocrinology. 1997 Jan;22(1):25-38 15935549 - Mol Cell Endocrinol. 2005 Jul 15;239(1-2):37-44 8163147 - Gastrointest Endosc. 1994 Jan-Feb;40(1):86-8 15753241 - Arch Gen Psychiatry. 2005 Mar;62(3):282-8 9508043 - Neuroendocrinology. 1998 Feb;67(2):126-38 10762519 - Neurology. 2000 Apr 25;54(8):1691-3 9397425 - Neuropsychopharmacology. 1997 Dec;17(6):370-81 1897330 - Acta Endocrinol (Copenh). 1991 Aug;125(2):132-7 7870916 - Psychopharmacology (Berl). 1993;110(4):451-9 16724185 - Psychopharmacology (Berl). 2006 Aug;187(2):209-21 12559121 - Neuropharmacology. 2003 Jan;44(1):49-55 24572042 - Biol Mood Anxiety Disord. 2014 Feb 26;4(1):3 11817760 - Addict Behav. 2002 Mar-Apr;27(2):167-77 18031826 - J Affect Disord. 2008 May;108(1-2):87-94 15110926 - Psychoneuroendocrinology. 2004 Jul;29(6):767-77 25098348 - J Womens Health (Larchmt). 2014 Sep;23(9):729-39 1846868 - J Clin Endocrinol Metab. 1991 Feb;72(2):252A-252F 1966304 - Psychoneuroendocrinology. 1990;15(5-6):489-93 16720657 - J Clin Endocrinol Metab. 2006 Aug;91(8):3092-9 1879162 - Cortex. 1991 Jun;27(2):333-7 16938407 - Neuroscience. 2006 Nov 17;143(1):73-81 25505380 - Front Neurosci. 2014 Nov 24;8:380 9659856 - Am J Psychiatry. 1998 Jul;155(7):910-3 25459890 - Psychoneuroendocrinology. 2015 Feb;52:22-31 23624686 - Arch Womens Ment Health. 2013 Aug;16(4):279-91 1447545 - J Exp Anal Behav. 1992 Nov;58(3):577-87 4565340 - Acta Psychiatr Scand Suppl. 1972;236:1-86 7790929 - J Neurosci. 1995 Jun;15(6):4641-50 11915576 - Gynecol Endocrinol. 2002 Feb;16(1):1-8 19398092 - Am J Obstet Gynecol. 2009 Aug;201(2):139.e1-8
References_xml	– volume: 982 start-page: 45 issue: 1 year: 2003 end-page: 53 ident: CR48 article-title: Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3beta-hydroxy-5alpha-pregnan-20-one (isoallopregnanolone) publication-title: Brain Res doi: 10.1016/S0006-8993(03)02939-1 – volume: 23 start-page: 257 issue: 5 year: 2007 end-page: 66 ident: CR1 article-title: Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome publication-title: Gynecol Endocrinol doi: 10.1080/09513590701253511 – ident: CR4 – ident: CR39 – ident: CR16 – ident: CR51 – volume: 72 start-page: 252A issue: 2 year: 1991 end-page: 252F ident: CR12 article-title: Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-72-2-252 – ident: CR54 – ident: CR61 – ident: CR8 – ident: CR58 – ident: CR25 – ident: CR42 – ident: CR46 – ident: CR19 – volume: 8 start-page: 380 year: 2014 ident: CR7 article-title: Menstrual cycle influence on cognitive function and emotion processing-from a reproductive perspective publication-title: Front Neurosci – volume: 67 start-page: 159 issue: 2 year: 1988 end-page: 66 ident: CR10 article-title: Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo publication-title: Acta Obstet Gynecol Scand doi: 10.3109/00016348809004191 – volume: 40 start-page: 86 issue: 1 year: 1994 end-page: 8 ident: CR22 article-title: Paradoxical reaction to midazolam and control with flumazenil publication-title: Gastrointest Endosc doi: 10.1016/S0016-5107(94)70020-6 – volume: 27 start-page: 167 issue: 2 year: 2002 end-page: 77 ident: CR23 article-title: The effects of diazepam (valium) and aggressive disposition on human aggression: an experimental investigation publication-title: Addict Behav doi: 10.1016/S0306-4603(00)00175-1 – ident: CR15 – ident: CR50 – ident: CR11 – ident: CR9 – volume: 110 start-page: 451 issue: 4 year: 1993 end-page: 9 ident: CR34 article-title: “Anxiolytic” and “anxiogenic” benzodiazepines and beta-carbolines: effects on aggressive and social behavior in rats and squirrel monkeys publication-title: Psychopharmacol (Berl) doi: 10.1007/BF02244652 – ident: CR60 – ident: CR36 – volume: 27 start-page: 333 issue: 2 year: 1991 end-page: 7 ident: CR27 article-title: Severe negative emotional reactions in intracarotid sodium amytal procedures: further evidence for hemispheric asymmetries? publication-title: Cortex doi: 10.1016/S0010-9452(13)80139-6 – volume: 169 start-page: 333 issue: 4 year: 2000 end-page: 41 ident: CR49 article-title: The inhibitory effects of allopregnanolone and pregnanolone on the population spike, evoked in the rat hippocampal CA1 stratum pyramidale in vitro, can be blocked selectively by epiallopregnanolone publication-title: Acta Physiol Scand doi: 10.1046/j.1365-201x.2000.00744.x – volume: 15 start-page: 4641 issue: 6 year: 1995 end-page: 50 ident: CR57 article-title: Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats publication-title: J Neurosci – volume: 44 start-page: 242 issue: 3 year: 2003 end-page: 57 ident: CR32 article-title: Neurosteroids, GABAA receptors, and escalated aggressive behavior publication-title: Horm Behav doi: 10.1016/j.yhbeh.2003.04.002 – volume: 17 start-page: 370 issue: 6 year: 1997 end-page: 81 ident: CR44 article-title: Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(97)00086-9 – ident: CR18 – ident: CR43 – volume: 58 start-page: 577 issue: 3 year: 1992 end-page: 87 ident: CR29 article-title: Effects of response requirement and alcohol on human aggressive responding publication-title: J Exp Anal Behav doi: 10.1901/jeab.1992.58-577 – ident: CR47 – ident: CR2 – ident: CR37 – ident: CR53 – volume: 73 start-page: 183- year: 2001 end-page: 191 ident: CR5 article-title: Premenstrual syndrome publication-title: nternational Journal of Gynecology & Obstetrics – ident: CR33 – ident: CR6 – ident: CR56 – ident: CR40 – volume: 22 start-page: 25 issue: 1 year: 1997 end-page: 38 ident: CR45 article-title: Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study publication-title: Psychoneuroendocrinology doi: 10.1016/S0306-4530(96)00035-2 – ident: CR63 – volume: 11 start-page: 99S issue: Suppl 1 year: 1981 end-page: 04S ident: CR21 article-title: Paradoxical reactions to benzodiazepines publication-title: Br J Clin Pharmacol – ident: CR3 – ident: CR38 – volume: 764 start-page: 173 issue: 1-2 year: 1997 end-page: 8 ident: CR13 article-title: Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states publication-title: Brain Res doi: 10.1016/S0006-8993(97)00455-1 – ident: CR52 – ident: CR17 – ident: CR31 – volume: 338 start-page: 209 issue: 4 year: 1998 end-page: 16 ident: CR14 article-title: Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome publication-title: N Engl J Med doi: 10.1056/NEJM199801223380401 – volume: 79 start-page: 405 issue: 5 year: 2000 end-page: 13 ident: CR26 article-title: Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives publication-title: Acta Obstet Gynecol Scand doi: 10.1080/j.1600-0412.2000.079005405.x – volume: 57 start-page: 178 issue: 2 year: 1996 end-page: 86 ident: CR30 article-title: The effects of alcohol on the aggressive responding of women publication-title: J Stud Alcohol doi: 10.15288/jsa.1996.57.178 – ident: CR55 – ident: CR59 – ident: CR28 – ident: CR41 – ident: CR62 – ident: CR24 – volume: 54 start-page: 238 issue: 3 year: 2006 end-page: 44 ident: CR35 article-title: Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone publication-title: Maturitas doi: 10.1016/j.maturitas.2005.11.005 – ident: CR20 – volume: 27 start-page: 167 issue: 2 year: 2002 ident: 627_CR23 publication-title: Addict Behav doi: 10.1016/S0306-4603(00)00175-1 – ident: 627_CR31 – volume: 23 start-page: 257 issue: 5 year: 2007 ident: 627_CR1 publication-title: Gynecol Endocrinol doi: 10.1080/09513590701253511 – ident: 627_CR19 doi: 10.1016/0306-4530(90)90072-H – ident: 627_CR62 doi: 10.1176/ajp.156.6.902 – ident: 627_CR37 doi: 10.1001/archpsyc.62.3.282 – ident: 627_CR56 doi: 10.1176/ajp.155.7.910 – ident: 627_CR53 doi: 10.1016/j.neuroscience.2006.07.031 – ident: 627_CR16 doi: 10.1016/j.psyneuen.2004.07.003 – volume: 54 start-page: 238 issue: 3 year: 2006 ident: 627_CR35 publication-title: Maturitas doi: 10.1016/j.maturitas.2005.11.005 – ident: 627_CR42 doi: 10.1186/2045-5380-4-3 – ident: 627_CR24 doi: 10.1212/WNL.54.8.1691 – ident: 627_CR41 doi: 10.1196/annals.1286.005 – ident: 627_CR59 doi: 10.1111/apha.12100 – volume: 67 start-page: 159 issue: 2 year: 1988 ident: 627_CR10 publication-title: Acta Obstet Gynecol Scand doi: 10.3109/00016348809004191 – volume: 8 start-page: 380 year: 2014 ident: 627_CR7 publication-title: Front Neurosci – ident: 627_CR61 doi: 10.1089/jwh.2013.4674 – ident: 627_CR17 doi: 10.1007/s00213-006-0417-0 – ident: 627_CR46 doi: 10.1016/S0306-4530(03)00121-5 – volume: 57 start-page: 178 issue: 2 year: 1996 ident: 627_CR30 publication-title: J Stud Alcohol doi: 10.15288/jsa.1996.57.178 – volume: 110 start-page: 451 issue: 4 year: 1993 ident: 627_CR34 publication-title: Psychopharmacol (Berl) doi: 10.1007/BF02244652 – ident: 627_CR8 doi: 10.1097/00006842-198312000-00004 – ident: 627_CR55 doi: 10.1016/S0306-4530(03)00026-X – ident: 627_CR9 doi: 10.1016/j.pneurobio.2013.07.005 – ident: 627_CR2 doi: 10.1111/j.1600-0412.2012.01536.x – ident: 627_CR15 doi: 10.1016/j.ajog.2009.03.016 – volume: 17 start-page: 370 issue: 6 year: 1997 ident: 627_CR44 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(97)00086-9 – volume: 764 start-page: 173 issue: 1-2 year: 1997 ident: 627_CR13 publication-title: Brain Res doi: 10.1016/S0006-8993(97)00455-1 – volume: 338 start-page: 209 issue: 4 year: 1998 ident: 627_CR14 publication-title: N Engl J Med doi: 10.1056/NEJM199801223380401 – volume: 58 start-page: 577 issue: 3 year: 1992 ident: 627_CR29 publication-title: J Exp Anal Behav doi: 10.1901/jeab.1992.58-577 – ident: 627_CR51 doi: 10.1016/j.psyneuen.2014.10.025 – volume: 72 start-page: 252A issue: 2 year: 1991 ident: 627_CR12 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-72-2-252 – ident: 627_CR58 doi: 10.1016/S0028-3908(02)00341-6 – volume: 79 start-page: 405 issue: 5 year: 2000 ident: 627_CR26 publication-title: Acta Obstet Gynecol Scand doi: 10.1080/j.1600-0412.2000.079005405.x – volume: 22 start-page: 25 issue: 1 year: 1997 ident: 627_CR45 publication-title: Psychoneuroendocrinology doi: 10.1016/S0306-4530(96)00035-2 – volume: 44 start-page: 242 issue: 3 year: 2003 ident: 627_CR32 publication-title: Horm Behav doi: 10.1016/j.yhbeh.2003.04.002 – ident: 627_CR43 doi: 10.1016/j.jad.2007.09.015 – ident: 627_CR28 doi: 10.1212/WNL.38.8.1233 – ident: 627_CR54 doi: 10.1210/jc.2005-2785 – ident: 627_CR39 doi: 10.1210/jc.2004-0444 – ident: 627_CR52 – ident: 627_CR60 doi: 10.1007/s00213-014-3776-y – ident: 627_CR18 doi: 10.1210/jc.2002-020755 – ident: 627_CR47 doi: 10.1159/000054307 – ident: 627_CR3 doi: 10.1016/j.mce.2005.04.007 – volume: 11 start-page: 99S issue: Suppl 1 year: 1981 ident: 627_CR21 publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.1981.tb01844.x – ident: 627_CR40 doi: 10.1016/j.psyneuen.2014.07.025 – ident: 627_CR38 doi: 10.1523/JNEUROSCI.1715-07.2007 – volume: 15 start-page: 4641 issue: 6 year: 1995 ident: 627_CR57 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.15-06-04641.1995 – ident: 627_CR4 doi: 10.1176/appi.books.9780890425596 – volume: 169 start-page: 333 issue: 4 year: 2000 ident: 627_CR49 publication-title: Acta Physiol Scand doi: 10.1046/j.1365-201x.2000.00744.x – ident: 627_CR20 doi: 10.1080/gye.16.1.1.8 – ident: 627_CR25 doi: 10.1097/00003643-200112000-00002 – ident: 627_CR11 doi: 10.1530/acta.0.1250132 – ident: 627_CR36 doi: 10.1038/sj.mp.4002030 – ident: 627_CR6 doi: 10.1007/s00737-013-0346-y – volume: 27 start-page: 333 issue: 2 year: 1991 ident: 627_CR27 publication-title: Cortex doi: 10.1016/S0010-9452(13)80139-6 – ident: 627_CR33 doi: 10.1007/s00213-004-1987-3 – volume: 982 start-page: 45 issue: 1 year: 2003 ident: 627_CR48 publication-title: Brain Res doi: 10.1016/S0006-8993(03)02939-1 – volume: 73 start-page: 183- year: 2001 ident: 627_CR5 publication-title: nternational Journal of Gynecology & Obstetrics – ident: 627_CR63 doi: 10.1001/archpsyc.1990.01810180034006 – volume: 40 start-page: 86 issue: 1 year: 1994 ident: 627_CR22 publication-title: Gastrointest Endosc doi: 10.1016/S0016-5107(94)70020-6 – ident: 627_CR50 doi: 10.1016/j.ejphar.2005.01.049 – reference: 25222701 - Psychoneuroendocrinology. 2014 Dec;50:28-52 – reference: 7790929 - J Neurosci. 1995 Jun;15(6):4641-50 – reference: 24572042 - Biol Mood Anxiety Disord. 2014 Feb 26;4(1):3 – reference: 9141149 - Psychoneuroendocrinology. 1997 Jan;22(1):25-38 – reference: 16938407 - Neuroscience. 2006 Nov 17;143(1):73-81 – reference: 7870916 - Psychopharmacology (Berl). 1993;110(4):451-9 – reference: 8163147 - Gastrointest Endosc. 1994 Jan-Feb;40(1):86-8 – reference: 9508043 - Neuroendocrinology. 1998 Feb;67(2):126-38 – reference: 23978486 - Prog Neurobiol. 2014 Feb;113:88-94 – reference: 17558683 - Gynecol Endocrinol. 2007 May;23(5):257-66 – reference: 1846868 - J Clin Endocrinol Metab. 1991 Feb;72(2):252A-252F – reference: 23510409 - Acta Physiol (Oxf). 2013 Aug;208(4):400-9 – reference: 11817760 - Addict Behav. 2002 Mar-Apr;27(2):167-77 – reference: 11737177 - Eur J Anaesthesiol. 2001 Dec;18(12):789-97 – reference: 3140572 - Acta Obstet Gynecol Scand. 1988;67(2):159-66 – reference: 12915239 - Brain Res. 2003 Aug 22;982(1):45-53 – reference: 22924787 - Acta Obstet Gynecol Scand. 2012 Dec;91(12):1445-52 – reference: 19398092 - Am J Obstet Gynecol. 2009 Aug;201(2):139.e1-8 – reference: 15486056 - J Clin Endocrinol Metab. 2005 Jan;90(1):395-403 – reference: 15316711 - Psychopharmacology (Berl). 2005 Mar;178(2-3):232-40 – reference: 17942736 - J Neurosci. 2007 Oct 17;27(42):11416-23 – reference: 14609546 - Horm Behav. 2003 Sep;44(3):242-57 – reference: 15814085 - Eur J Pharmacol. 2005 Apr 4;512(1):15-21 – reference: 1879162 - Cortex. 1991 Jun;27(2):333-7 – reference: 9397425 - Neuropsychopharmacology. 1997 Dec;17(6):370-81 – reference: 9659856 - Am J Psychiatry. 1998 Jul;155(7):910-3 – reference: 1897330 - Acta Endocrinol (Copenh). 1991 Aug;125(2):132-7 – reference: 10762519 - Neurology. 2000 Apr 25;54(8):1691-3 – reference: 15935549 - Mol Cell Endocrinol. 2005 Jul 15;239(1-2):37-44 – reference: 16406399 - Maturitas. 2006 Jun 20;54(3):238-44 – reference: 15110926 - Psychoneuroendocrinology. 2004 Jul;29(6):767-77 – reference: 25345735 - Psychopharmacology (Berl). 2016 Jun;233(11):2025-33 – reference: 6133541 - Br J Clin Pharmacol. 1981;11 Suppl 1:99S-104S – reference: 16720657 - J Clin Endocrinol Metab. 2006 Aug;91(8):3092-9 – reference: 9295207 - Brain Res. 1997 Aug 1;764(1-2):173-8 – reference: 10951125 - Acta Physiol Scand. 2000 Aug;169(4):333-41 – reference: 1447545 - J Exp Anal Behav. 1992 Nov;58(3):577-87 – reference: 25459890 - Psychoneuroendocrinology. 2015 Feb;52:22-31 – reference: 11915576 - Gynecol Endocrinol. 2002 Feb;16(1):1-8 – reference: 14993039 - Ann N Y Acad Sci. 2003 Dec;1007:42-53 – reference: 18031826 - J Affect Disord. 2008 May;108(1-2):87-94 – reference: 3399074 - Neurology. 1988 Aug;38(8):1233-6 – reference: 17579609 - Mol Psychiatry. 2008 Mar;13(3):325-33 – reference: 16724185 - Psychopharmacology (Berl). 2006 Aug;187(2):209-21 – reference: 15471618 - Psychoneuroendocrinology. 2005 Feb;30(2):212-24 – reference: 14604604 - Psychoneuroendocrinology. 2004 Feb;29(2):245-68 – reference: 23624686 - Arch Womens Ment Health. 2013 Aug;16(4):279-91 – reference: 2161643 - Arch Gen Psychiatry. 1990 Jun;47(6):534-8 – reference: 12727949 - J Clin Endocrinol Metab. 2003 May;88(5):2026-30 – reference: 9435325 - N Engl J Med. 1998 Jan 22;338(4):209-16 – reference: 15753241 - Arch Gen Psychiatry. 2005 Mar;62(3):282-8 – reference: 6686333 - Psychosom Med. 1983 Dec;45(6):503-7 – reference: 12559121 - Neuropharmacology. 2003 Jan;44(1):49-55 – reference: 25098348 - J Womens Health (Larchmt). 2014 Sep;23(9):729-39 – reference: 8683967 - J Stud Alcohol. 1996 Mar;57(2):178-86 – reference: 25505380 - Front Neurosci. 2014 Nov 24;8:380 – reference: 4565340 - Acta Psychiatr Scand Suppl. 1972;236:1-86 – reference: 1966304 - Psychoneuroendocrinology. 1990;15(5-6):489-93 – reference: 10830769 - Acta Obstet Gynecol Scand. 2000 May;79(5):405-13 – reference: 10360130 - Am J Psychiatry. 1999 Jun;156(6):902-7
SSID	ssj0020082
Score	2.2127955
SecondaryResourceType	review_article
Snippet	In certain women, increased negative mood relates to the progesterone metabolite, allopregnanolone (allo), during the luteal phase of ovulatory menstrual...
SourceID	proquest pubmed crossref springer
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	92
SubjectTerms	Affect - drug effects Affect - physiology Female GABA Modulators - metabolism GABA Modulators - pharmacology Humans Medicine Medicine & Public Health Menstrual Cycle - drug effects Menstrual Cycle - metabolism Neurotransmitters Pregnanolone - metabolism Premenstrual Dysphoric Disorder - metabolism Premenstrual Dysphoric Disorder - psychology Premenstrual Dysphoric Disorder - therapy Psychiatry Receptors, GABA-A - metabolism Section Editor Steroids Topical Collection on Women's Mental Health Women's Mental Health (CN Epperson
SummonAdditionalLinks	– databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD7oFPHF-6U6JYJPSmBr07V53MTpy4a4IXsrbS4ykHasm8_-Df-ev8ST3oZMBX0rJE2Tk6Tn-zg3gMtIaK-JjVQY-MYk82jYDDVF8Mu11iEyjrzYhNfv-6MRfyjiuNPS2700SWZ_6kWwG4IR40TlUpNal7JVWENt55vb-Dh4qliWUWpZklTboaiO7NKU-d0QX5XREsJcso5mSqe7_a_p7sBWgTFJOz8Uu7Ci4j3Y6BVW9H3o3bU77TZBxKgmSLlpL5FZEa_4mQxQzMlYpmQck9JPjswSkhW6_Hh7T0mniusneQjTAQy7t8Obe1qUVaDC8ewZ1coXiKlFKJnraSQYvnLCqKVbQnCHKd_FhyZTqL-URH6lpUQKwiVvqYb2IukcQi1OYnUMRGmJFM5hMow4E2EUIT9pcOWwlht5rhYWNErxBqJIOW4qX7wEi2TJRkoBSikwUgqYBVfVK5M838ZvnevlngXF1UuDLJYXgaTvW3BRNeOlMZaQMFbJPA2aSGJNzWXOLTjK97r6Gi7IZOGzLbguN3Yx-I9TOflT71PYtM3JyGIa61CbTefqDNbF62ycTs-z8_wJGfPuOA priority: 102 providerName: Springer Nature
Title	GABAA Receptor-Modulating Steroids in Relation to Women’s Behavioral Health
URI	https://link.springer.com/article/10.1007/s11920-015-0627-4 https://www.ncbi.nlm.nih.gov/pubmed/26396092 https://www.proquest.com/docview/2406908588 https://www.proquest.com/docview/1717473599
Volume	17
WOSCitedRecordID	wos000361741100007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1535-1645 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0020082 issn: 1523-3812 databaseCode: BENPR dateStart: 19990601 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database (ProQuest) customDbUrl: eissn: 1535-1645 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0020082 issn: 1523-3812 databaseCode: M2M dateStart: 19990601 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1535-1645 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0020082 issn: 1523-3812 databaseCode: RSV dateStart: 19990601 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50FfHi-1FfRPCkBHfbdNucZFd8XLqIiuyttHnIgrSrXT37N_x7_hInbdpFRC9eSkv6SDNJ5vsymRmAo1TooIOFVBj4xiQLaNJJNEXwy7XWCTKOKtlEMBiEwyG_sQtuhd1WWc-J5UQtc2HWyE9LF03EB2F4Nn6mJmuUsa7aFBqzMGcilbEWzPUvBje3DeUyGq6MmOp6FHWTW9s1S-c5BDdmU5ZPTaheyr5rph9w84eptNRAl8v_rfsKLFnsSXpVZ1mFGZWtwUJkrevrEF31-r0eQSSpxkjFaZTLMrlX9kjusPnzkSzIKCP1_jkyyUmZAPPz_aMg_cbfn1SuTRtwf3lxf35NbboFKrzAnVCtQoFYWySS-YFG4hEqL0m7uisE95gKfTzpMIV6TUnkXVpKpCZc8q5q6yCV3ia0sjxT20CUlkjtPCaTlDORpCnyljZXHuv6aeBr4UC7bulY2FDkJiPGUzwNomyEE6NwYiOcmDlw3DwyruJw_HXzXi2H2A7JIp4KwYHDphgHk7GQJJnKX4u4g-TW5GLm3IGtSuzN1_CHTHQ-14GTuh9MX_5rVXb-rsouLLqmB5bOjXvQmry8qn2YF2-TUfFyALPBMDywfRqvIjfC4-3dwxfTGv06
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL1qh4qyKVBe6QNcCTZUFjOJM4kXFZpSSqs2o0qdRXdW4gcaqUqGSQpix2_wEfwUX8K18xihqt110V0kJ44dH1-fG_veA_A2kyYaYCGVlr4xxSKaDlJDkfxyY0yKHkctNhGNx_HFBT9bgj9tLIw9VtnaRGeoVSHtP_IPLkQT-UEcf5x9o1Y1yu6uthIaNSxO9M8f6LKVe8cHOL7vfP_w8-TTEW1UBagMIr-iRscSKaVMFQsjg_w61kGaDc1QSh4wHYd4MWAazbdW6F4YpZCBc8WHum-iTAVY7TI8YOgIWaWIxE86_84upy49qx9QXAj9dhPVReohk7InwEJq8wJT9v8yeI3bXtuXdcvd4eN79qGewFrDq8monghPYUnn6_AwaU4OPIPky2h_NCLIkvWsKuY0KZQTLsu_knOEVjFVJZnmpD0bSKqCOHHPv79-l2S_y2VA6rCt5zC5i768gF5e5PoVEG0Uuq0BU2nGmUyzDH2yPtcBG4ZZFBrpQb8dWCGbNOtW7eNSLBJEWywIxIKwWBDMg_fdI7M6x8htN2-1wy4ac1OKxZh7sNMVo6Gwuz9prourUgzQcbc605x78LJGWfc27JDNPOh7sNvCblH5jU3ZuL0pb2D1aJKcitPj8ckmPPIt-F0Q5xb0qvmV3oYV-b2alvPXbhoREHeMxn8G71bl
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ba9swFD507Qh92bpLV7fppsGeVkRiW46tx2Rr1tImBBJG3oStSwkMO8Tunvc39vf2S3bkWxjZBqVvBsmyfCRxvo-jcz6AD4k0oYuNVFr4xhQLaezGhiL45caYGBlHJTYRTqfRcslntc5p3tx2b0KSVU6DrdKUFr21Mr1t4hsCE3uhKqC2zC5lT-CAWc0gS9fnX1vGZR1cWTDV8ym6Jq8Ja_5tiD8d0w7a3ImUlg5o_PzRUz-CZzX2JMNqs7yAPZ2-hM6kjq6_gsmX4Wg4JIgk9RqpOJ1kqhT3Su_IHM2frVROVilp7s-RIiOlAOavHz9zMmrz_UmV2vQaFuPLxacrWsstUOmHXkGNjiRibRkrFoQGiUek_TgZmIGU3Gc6CvDBZRr9mlbIu4xSSE244gPdN2Gi_GPYT7NUnwDRRiG185mKE85knCTIW_pc-2wQJGFgpAP9xtRC1qXIrSLGN7EtomytJNBKwlpJMAc-tq-sqzoc_-vcbdZP1EcyF2WOLwLMKHLgfduMh8lGSOJUZ_e5cJHcWi1mzh14U617-zX8IVudz3Pgolnk7eD_nMrpg3q_g87s81jcXk9vzuDQs5ukTHvswn6xudfn8FR-L1b55m25zX8DjGr6AA
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GABAA+Receptor-Modulating+Steroids+in+Relation+to+Women%E2%80%99s+Behavioral+Health&rft.jtitle=Current+psychiatry+reports&rft.au=B%C3%A4ckstr%C3%B6m%2C+Torbj%C3%B6rn&rft.au=Bixo%2C+Marie&rft.au=Str%C3%B6mberg%2C+Jessica&rft.date=2015-11-01&rft.issn=1523-3812&rft.eissn=1535-1645&rft.volume=17&rft.issue=11&rft_id=info:doi/10.1007%2Fs11920-015-0627-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11920_015_0627_4
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1523-3812&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1523-3812&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1523-3812&client=summon